Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CARDINAL HEALTH INC | Director | Common Shares | 3.02K | $330K | $109.39 | Nov 6, 2024 | Direct |
ADC Therapeutics SA | Director | Common Shares | 53K | $153K | $2.89 | Jun 17, 2024 | Direct |
Eliem Therapeutics, Inc. | President & CEO, Director | Stock Option (Right to Buy) | 500K | Oct 31, 2022 | Direct | ||
Clovis Oncology, Inc. | Director | Stock Option (right to buy) | 42.2K | Jun 10, 2021 | Direct | ||
CHINOOK THERAPEUTICS, INC. | Director | Restricted Stock Units | 0 | Aug 11, 2023 | Direct | ||
CHINOOK THERAPEUTICS, INC. | Director | Stock Option (Right to Buy) | 0 | $26.12 | Aug 11, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CAH | CARDINAL HEALTH INC | Nov 6, 2024 | 1 | $0 | 4 | Nov 7, 2024 | Director |
ADCT | ADC Therapeutics SA | Jun 17, 2024 | 1 | -$20.2K | 4 | Jun 18, 2024 | Director |
ADCT | ADC Therapeutics SA | Jun 13, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
CAH | CARDINAL HEALTH INC | Mar 15, 2024 | 1 | $0 | 4 | Mar 18, 2024 | Director |
CAH | CARDINAL HEALTH INC | Mar 1, 2024 | 0 | $0 | 3 | Mar 1, 2024 | Director |
ADCT | ADC Therapeutics SA | Jan 2, 2024 | 0 | $0 | 3 | Jan 2, 2024 | Director |
KDNY | CHINOOK THERAPEUTICS, INC. | Aug 11, 2023 | 2 | -$519K | 4 | Aug 11, 2023 | Director |
KDNY | CHINOOK THERAPEUTICS, INC. | Apr 10, 2023 | 2 | $0 | 4 | Apr 12, 2023 | Director |
KDNY | CHINOOK THERAPEUTICS, INC. | Apr 10, 2023 | 0 | $0 | 3 | Apr 12, 2023 | Director |
ELYM | Eliem Therapeutics, Inc. | Oct 31, 2022 | 1 | $0 | 4 | Nov 2, 2022 | President & CEO, Director |
ELYM | Eliem Therapeutics, Inc. | Jan 27, 2022 | 1 | $0 | 4 | Jan 31, 2022 | President & CEO, Director |
ELYM | Eliem Therapeutics, Inc. | Aug 9, 2021 | 0 | $0 | 3 | Aug 9, 2021 | Chief Executive Officer, Director |
CLVS | Clovis Oncology, Inc. | Jun 10, 2021 | 1 | $0 | 4 | Jun 11, 2021 | Director |